Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Nozomi Tochiki, Takeshi Nakamura, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masayuki Nashimoto, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 2461.

https://doi.org/10.1182/blood.V114.22.2461.2461

Published: 2009

Journal Articles

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

Anri Saitoh, Miwako Narita, MD, Akie Yamahira, Takeshi Nakamura, Nozomi Tochiki, Norihiro Watanabe, Masami Kaji, Tomoyo Taniguchi, Masayoshi Masuko, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 4253.

https://doi.org/10.1182/blood.V114.22.4253.4253

Published: 2009

Journal Articles

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Takeshi Nakamura, Miwako Narita, MD, Akie Yamahira, Norihiro Watanabe, Nozomi Tochiki, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 5117.

https://doi.org/10.1182/blood.V114.22.5117.5117

Published: 2009

Journal Articles

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Noriyuki Satoh, Toshio Yano, MD, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4762.

https://doi.org/10.1182/blood.V110.11.4762.4762

Published: 2007

Journal Articles

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

Nozomi Tochiki, Miwako Narita, MD, Zhiyin Zheng, MD, Chengfang Lu, MD, Norihiro Watanabe, Anri Saitoh, Noriyuki Satoh, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4897.

https://doi.org/10.1182/blood.V110.11.4897.4897

Published: 2007

Journal Articles

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Yumi Hiroi, Takayoshi Shirasaki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Sadao Aoki, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 3895.

https://doi.org/10.1182/blood.V108.11.3895.3895

Published: 2006

Journal Articles

Remarkable Positive Correlation of Blood Monocyte Counts with Blood Plasmacytoid Dendritic Cells and Blood Regulatory T Cells.

Norihiro Watanabe, Miwako Narita, Anri Saito, Nozomi Tochiki, Miku Satoh, Noriyuki Satoh, Haruka Kanii, Masayoshi Masuko, Tatsuo Furukawa, Ken Toba, Sadao Aoki, Ichiro Fuse, Yoshifusa Aizawa, Masuhiro Takahashi

Blood (2006) 108 (11): 3853.

https://doi.org/10.1182/blood.V108.11.3853.3853

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Norihiro Watanabe, Anri Saitoh, Shigeo Hashimoto, MD, Junjiro Tsuchiyama, MD, Tatsuo Furukawa, MD, Sadao Aoki, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 4456.

https://doi.org/10.1182/blood.V108.11.4456.4456

Published: 2006

Journal Articles

BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma.

Jun Takizawa, Sadao Aoki, Akihito Momoi, Toshiki Kitajima, Masutaka Higashimura, Naoya Nakamura, Yoshifusa Aizawa

Blood (2006) 108 (11): 4620.

https://doi.org/10.1182/blood.V108.11.4620.4620

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Shigeo Hashimoto, MD, Asuka Sekiguchi, Norihiro Watanabe, Ayumi Yokoyama, Anri Saitoh, Junjiro Tsuchiyama, MD, Toshio Yano, MD, Masayoshi Masuko, MD, Ken Toba, MD, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 4330.

https://doi.org/10.1182/blood.V106.11.4330.4330

Published: 2005

Journal Articles

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Norihiro Watanabe, Miwako Narita, MD, Ayumi Yokoyama, Asuka Sekiguchi, Anri Saito, Nozomi Tochiki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2383.

https://doi.org/10.1182/blood.V106.11.2383.2383

Published: 2005

Journal Articles

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Ayumi Yokoyama, Asuka Sekiguchi, Nozomi Tochiki, Louie Alldawi, MD, Jun Takizawa, MD, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2385.

https://doi.org/10.1182/blood.V106.11.2385.2385

Published: 2005

Journal Articles

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Yoshinobu Seki, MD, Kazue Takai, MD, Koji Nikkuni, MD, PhD, Souichi Maruyama, MD, PhD, Nobuhiko Nomoto, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yoshifusa Aizawa, MD

Blood (2005) 106 (11): 5350.

https://doi.org/10.1182/blood.V106.11.5350.5350

Published: 2005

Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD

Blood (2004) 104 (11): 5076.

https://doi.org/10.1182/blood.V104.11.5076.5076

Published: 2004

Journal Articles

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Masutaka Higashimura, MD, Akihito Momoi, MD, Nobuhiro Tsukada, MD, PhD, Koji Nikkuni, MD, PhD, Nobuhiko Nomoto, MD, PhD, Yoshifusa Aizawa, MD

Blood (2004) 104 (11): 5207.

https://doi.org/10.1182/blood.V104.11.5207.5207

Published: 2004

Journal Articles

Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation

Nobuhiro Tsukada, Hisaya Akiba, Tetsuji Kobata, Yoshifusa Aizawa, Hideo Yagita, Ko Okumura

Blood (2000) 95 (7): 2434–2439.

https://doi.org/10.1182/blood.V95.7.2434

Published: 2000

Journal Articles

Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation

Nobuhiro Tsukada, Tetsuji Kobata, Yoshifusa Aizawa, Hideo Yagita, Ko Okumura

Blood (1999) 93 (8): 2738–2747.

https://doi.org/10.1182/blood.V93.8.2738

Published: 1999

NARROW

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Remarkable Positive Correlation of Blood Monocyte Counts with Blood Plasmacytoid Dendritic Cells and Blood Regulatory T Cells.

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma.

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation

Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only